Pilot Study of Fecal Mitochondrial DNA in Inflammatory Bowel Disease Patients Demonstrates a High Sensitivity Assay With Likely Capacity to Differentiate Between Disease and Histologic Remission.

Zhu K, Wallach T, Sharma S, Vega V, Pittman M, Brown J

Open source

DOI
10.1016/j.gastha.2025.100622
Published
2025
Container
Gastro hep advances
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.gastha.2025.100622,
  title = {Pilot Study of Fecal Mitochondrial DNA in Inflammatory Bowel Disease Patients Demonstrates a High Sensitivity Assay With Likely Capacity to Differentiate Between Disease and Histologic Remission.},
  author = {Zhu K and Wallach T and Sharma S and Vega V and Pittman M and Brown J},
  year = {2025},
  journal = {Gastro hep advances},
  doi = {10.1016/j.gastha.2025.100622},
  url = {https://doi.org/10.1016/j.gastha.2025.100622}
}

RIS

TY  - JOUR
TI  - Pilot Study of Fecal Mitochondrial DNA in Inflammatory Bowel Disease Patients Demonstrates a High Sensitivity Assay With Likely Capacity to Differentiate Between Disease and Histologic Remission.
AU  - Zhu K
AU  - Wallach T
AU  - Sharma S
AU  - Vega V
AU  - Pittman M
AU  - Brown J
PY  - 2025
JO  - Gastro hep advances
DO  - 10.1016/j.gastha.2025.100622
UR  - https://doi.org/10.1016/j.gastha.2025.100622
ER  - 

APA

K, Z., T, W., S, S., V, V., M, P., & J, B. (2025). Pilot Study of Fecal Mitochondrial DNA in Inflammatory Bowel Disease Patients Demonstrates a High Sensitivity Assay With Likely Capacity to Differentiate Between Disease and Histologic Remission.. Gastro hep advances. https://doi.org/10.1016/j.gastha.2025.100622

Source records